Strategic Professor and Head of Clinical Pharmacology
Arduino trained in Clinical Pharmacology, Cardiology and Internal Medicine in Milan, Boston and London. In 2003 he was awarded a PhD at King's College London and was appointed as Senior Lecturer in the Department of Clinical Pharmacology at Flinders University. He was promoted to Associate Professor in 2007 before taking up the Chair of Medicine of Old Age at the University of Aberdeen in 2010. In 2013 he returned to Flinders University as Professor of Clinical Pharmacology and Senior Consultant in Clinical Pharmacology and Internal Medicine.
MD(Hons), University of Milan, 1991
PhD, King's College London, 2003
FRCP (London), 2009
FRCP (Glasgow), 2010
FRCP (Edinburgh), 2011
Kathleen Knights, Karen Lillywhite, Gail Easterbrook, John Miners and Arduino Mangoni, Carrick citation for outstanding contributions to student learning "For promotion of safe and effective medication management through an innovative e-learning pharmacology course for Nurse Practitioners in urban, rural and remote areas of Australia". (2007)
Visiting Professor, University of Sassari, Italy (2012, 2014, 2015)
2013: AA Mangoni, BC Lewis, A Rowland. Dimethylarginine dimethylaminohydrolase (DDAH) and angiogenesis modulation: a novel therapeutic target in cancer? Flinders Medical Centre (FMC) Foundation research grant, 1 year, AUD 15,000
2013: L Mayner, AA Mangoni, RJ Woodman. Are older people on anticholinergic medication at greater risk of hospitalisation during extreme heat conditions? Faculty of Health Sciences research grant, 1 year, AUD 12,000
2013: A Pilotto, M Mirandola, S Menichelli, I Jansson, M Nordenfelt, M Zoratti, S Maggi, L Ferrucci, AA Mangoni, RJ Woodman, F Pellegrini, A Greco, D Sancarlo, K Kinder, H Kolk, AS Parent, I Kiss, I Petrov. Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. European Commission, Second Health Programme (2008-2013), Ref: 508379, 3 years, EUR 837,572.
2014: MG Burt, CH Thompson, A Rowland, S Quinn, AA Mangoni. Does variability in glucocorticoid homeostasis affect insulin sensitivity and vascular function? Diabetes Australia, 1 year, $59,843
2015: AA Mangoni, A Rowland, J Miners, T Chataway, M Michael, MG Burt, D Keating, L Thurgood, M Sorich. Establishment of the Flinders Metabolomic Research facility. Flinders Faculty of Health Sciences Small Grants, AUD 20,000.
2015: MG Burt, AA Mangoni, L Heilbronn. Determination of the effect of relative hyperglycaemia on markers of cardiovascular risk. Flinders Faculty of Health Sciences Small Grants, AUD 19,000.
Arginine metabolomics in health and disease
Novel DDAH inhibitors as therapeutic agents in models of neurodegeneration
Cardiovascular toxicity of NSAIDs
Pharmacoepidemiology of antimuscarinic drugs and adverse effects in older patients
: Design of novel DDAH inhibitors (Univ of Aberdeen)
; Methotrexate and markers of cardiovascular risk in rheumatoid arthritis (Univ of Aberdeen)
Editor-in-Chief: Therapeutic Advances in Drug Safety
Associate Editor: Age & Ageing
Review Editor: British Journal of Clinical Pharmacology
Executive Member of the National Blood Pressure and Vascular Disease Advisory Committee: review and update of Australian Hypertension Guidelines
SIGN (Scottish Intercollegiate Guidelines Network) Working Group: Management of Chronic Pain
Clinical Pharmacology Consultant for Bellberry Human Research Ethics Committee
|Phone:||+61 8 82047495|
|Location:||Flinders Medical Centre (6D:302)|
|Postal address:||GPO Box 2100, Adelaide 5001, South Australia|